131 related articles for article (PubMed ID: 6324457)
1. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen.
Kishishita M; Luka J; Vroman B; Poduslo JF; Pearson GR
Virology; 1984 Mar; 133(2):363-75. PubMed ID: 6324457
[TBL] [Abstract][Full Text] [Related]
2. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
Qualtiere LF; Chase R; Vroman B; Pearson GR
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
[TBL] [Abstract][Full Text] [Related]
3. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,
Dalianis T; Klein G; Andersson B
Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus.
Vroman B; Luka J; Rodriguez M; Pearson GR
J Virol; 1985 Jan; 53(1):107-13. PubMed ID: 2981328
[TBL] [Abstract][Full Text] [Related]
6. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
8. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
9. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
10. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
11. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
12. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
[TBL] [Abstract][Full Text] [Related]
13. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms.
Kurakata S; Ramos OF; Klein G; Klein E
Cell Immunol; 1989 Oct; 123(1):134-47. PubMed ID: 2550147
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
Cho MS; Gissmann L; Hayward SD
Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
[TBL] [Abstract][Full Text] [Related]
15. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.
Pearson GR; Vroman B; Chase B; Sculley T; Hummel M; Kieff E
J Virol; 1983 Jul; 47(1):193-201. PubMed ID: 6306272
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
Qualtiere LF; Pearson GR
Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
[TBL] [Abstract][Full Text] [Related]
17. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
18. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
Fujiwara S; Takada K; Yano S; Osato T
Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus.
Takada K; Fujiwara S; Yano S; Osato T
Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479
[TBL] [Abstract][Full Text] [Related]
20. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]